Anthropic’s $2T IPO could create millionaires—but it’s asking candidates what they’d do if stock hit zero
As Anthropic targets a November IPO at a $1.5 trillion to $2 trillion valuation—potentially eclipsing SpaceX’s record—the blockbuster…
Anthropic IPO live updates: AI lab’s S-1 filing
Anthropic says dependence on TSMC for chip manufacturing is a risk Anthropic said the geographic concentration of advanced…
Trump’s ‘super intelligence’ is being mocked by tech industry insiders: report
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today.…
Anthropic reportedly looking to IPO as early as mid-November
Anthropic’s (ANTH.PVT) Thanksgiving looks like it may come with a heaping side of cash, as Bloomberg reports the…
Anthropic’s IPO prospectus shows sweeping AI vision, surging costs
By Echo Wang Sept 28 (Reuters) – Anthropic is making a massive bet that AI will transform the…
I Urge You to Urge Others to Watch the ‘SNL’ Segment About Dario Amodei
I have nothing against the honorable profession of writing blog posts on Sunday morning about the previous night’s…
Anthropic’s Dario Amodei gets the SNL treatment
Saturday Night Live took on the AI industry’s recent warnings of doom last night, as cast member Jane…
AI risks, Iran war to take center stage at UN
The future of artificial intelligence and the stalled US war against Iran, with its ripple effect on the…
Zuckerberg Challenges Anthropic Over Calls to Slow AI
Mark Zuckerberg is pushing back on one of Silicon Valley’s loudest calls to slam the brakes on…
Meet Anthropic CEO Dario Amodei’s handpicked super-woke globalists he thinks will save us from an AI apocalypse
Worried what AI will do to the world? Don’t fret — we got a group of woke elitists…
OpenAI, Anthropic, Google have been in talks on AI safety for weeks
Chris Lehane, OpenAI’s global policy chief, told reporters on Tuesday that the company has been working with rivals…
AI Leaders Picked a Convenient Time to Respond to Safety Worries
Imagine a pharmaceutical company spends nearly four years touting a ground-breaking new medicine that will cure all diseases.…